Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana, revealed it has teamed up with Amazon Pharmacy to help deliver its Zepbound weight loss drug and other medicines straight to customers' homes.
It struck a partnership deal with the online pharmacy subsidiary of Amazon Inc. just four months after obtaining the required regulatory approval to sell its diabetes treatment under a different name and category: weight loss.
Lilly's Weight Loss Treatment
According to CBS News, Eli Lilly's Tirzepatide drug, currently sold as a Mounjaro brand for diabetes, is now on the market under the new name Zepbound. It is also advertised as a weight-loss medication administered using an injection pen.
The company reportedly started selling Zepbound earlier this year. The drugs are directly sold to patients. Patients consult with doctors and obtain prescriptions from digital pharmacies, and the drugs are delivered to them.
Amazon Pharmacy Added as Home Delivery Option
Its partnership with Amazon's pharmacy unit allows patients and customers to obtain their medications quickly. In addition to Amazon Pharmacy, Eli Lilly delivers drugs to its customers via Truepill.
"Lilly has selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists," Dr. Vin Gupta, Amazon Pharmacy's chief medical officer, said in a press release. "To help patients being treated for diabetes, obesity, and migraine, Amazon Pharmacy is now offering home delivery of select medications through LillyDirect."
Dr. Gupta added, "Lilly has selected Amazon Pharmacy to serve as a third-party dispensing provider for LillyDirect Pharmacy Solutions, delivering prescribed Lilly medications directly to a patient's home."
Photo by: James Yarema/Unsplash


Prysmian, Rio Tinto Supply Low-Carbon Cables for Amazon Ohio Data Center
fnny Beta Launches With a Simple Idea: Find an Event, Show Up, Get Rewarded
SpaceX Nasdaq 100 Weight to More Than Double in Rebalance
Nike Earnings at Risk as UBS Cuts Price Target to $42
Meta Partners With Shopify to Bring Shop Pay Checkout to Muse AI
Hyundai CEO Warns Chinese Automakers Could Disrupt US Market
Paramount Skydance Faces $30 Million Film Penalty in Warner Bros. Deal
Volkswagen Shares Slide After 2026 Profit Outlook Cut
US Northeast Airports Resume Operations After Telecom Outage Disrupts Thousands of Flights
US Federal Register Drops Alibaba Qwen AI Search Tool
Petrobras Joins Brazil Diesel Subsidy Program
Westinghouse Targets $50 Billion Valuation in U.S. IPO
OpenAI Urges US-Led Global Standards for Frontier AI
White House Bars CNN, MS NOW and Politico Reporters
Supertanker Orders Surge as US-Iran War Reshapes Oil Trade
FCC Approves Foreign Investment in $110B Paramount-Warner Bros. Deal 



